InRange: Comparison of the Second-Generation Basal Insulin Analogues Glargine 300 U/mL and Degludec 100 U/mL in Persons With Type 1 Diabetes Using Continuous Glucose Monitoring—Study Design
Diabetes Therapy - United States
doi 10.1007/s13300-020-00781-6
Full Text
Open PDFAbstract
Available in full text
Date
February 25, 2020
Authors
Publisher
Springer Science and Business Media LLC